Fig. 7.
![Fig. 7. CD44 MoAbs and CD44-Rg inhibit CSB-induced PBMC proliferation. PBMC were incubated with CSB (1 mg/mL) with or without either the CD44 MoAb A3D8 (10 μg/mL; A), or CD44-Rg fusion protein (12 mg/mL ; B) for 6 days. [3H]-thymidine incorporation was measured in the last 16 hours of the experiment. The data were confirmed in three independent experiments.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/92/1/10.1182_blood.v92.1.223.413k15_223_229/5/blod41315007x.jpeg?Expires=1724252020&Signature=xtowReQ5aT0Wq6WbqQZoES7ocwi8LNSTOpXNRjlrzEl1DAeffwEsjKi-3mqCvUHOvFmeCjEZe3idOyhvHTeGbdalogESCk3rcSTYvBDea8qKQcGNQ091iOuwmM6Wumjv~3CYgUj94-YLTzO~i8~DTvXzP5Uatl4ex6mrGYkCCAHqBYXCHcBexsykG1P2IsGbGcTyZozHeS9pv8YF3Ux9cF7wTMLHh90dpx-Ak6k4O6Fb8x6mPi8wF4xZ5aqWVwlSV35iJoiijm~Oh-YspCt7T4xzuxzUe42J18cMHfa6hNNz~1gpBWcYIvmXkZYkuCGAPTVUsYhg4C-f~WZH~1wB6w__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
CD44 MoAbs and CD44-Rg inhibit CSB-induced PBMC proliferation. PBMC were incubated with CSB (1 mg/mL) with or without either the CD44 MoAb A3D8 (10 μg/mL; A), or CD44-Rg fusion protein (12 mg/mL ; B) for 6 days. [3H]-thymidine incorporation was measured in the last 16 hours of the experiment. The data were confirmed in three independent experiments.
